EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 142 filers reported holding EPIZYME INC in Q4 2020. The put-call ratio across all filers is 1.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $493,000 | -70.9% | 96,245 | -52.8% | 0.01% | -73.9% |
| Q2 2021 | $1,694,000 | +94.5% | 203,838 | +103.9% | 0.02% | +21.1% |
| Q1 2021 | $871,000 | -23.1% | 99,980 | -4.2% | 0.02% | -26.9% |
| Q4 2020 | $1,132,000 | -55.9% | 104,321 | -34.8% | 0.03% | -69.8% |
| Q2 2020 | $2,569,000 | +145.4% | 160,010 | +137.1% | 0.09% | +45.8% |
| Q1 2020 | $1,047,000 | +72.2% | 67,500 | +39.2% | 0.06% | +90.3% |
| Q2 2019 | $608,000 | – | 48,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $79,842,000 | 29.97% |
| Foresite Capital Management III, LLC | 998,278 | $8,695,000 | 7.64% |
| KPCB XIII Associates, LLC | 3,838,166 | $33,430,000 | 6.87% |
| Burrage Capital Management LLC | 564,555 | $4,917,000 | 3.98% |
| Palo Alto Investors LP | 6,856,513 | $59,720,000 | 3.40% |
| MPM BioImpact LLC | 2,331,534 | $20,308,000 | 2.55% |
| Foresite Capital Management II, LLC | 1,000,002 | $8,710,000 | 2.00% |
| Foresite Capital Management I, LLC | 293,759 | $2,559,000 | 1.29% |
| Redmile Group, LLC | 8,824,366 | $76,860,000 | 1.08% |
| Rock Springs Capital Management LP | 2,802,954 | $24,414,000 | 0.53% |